Randomized Phase II Trial of Continuous Versus Standard Capecitabine in Advanced Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Capecitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Aug 2011 Planned end date changed from Jun 2011 to Dec 2011 as reported by ClinicalTrials.gov.
- 17 Jun 2011 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2011 Preliminary analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.